Tag Archives: CDC

Refilling the Antibiotic Pipeline: How to Lead the Horse to Water?

By Clark Herman | Published: March 15, 2013
Last week, the United States Center for Disease Control (CDC) and Britain’s Chief Medical Officer issued separate warnings about the urgent problem of antibiotic resistance in infectious diseases. Given industry’s general lack of interest in developing new antibiotics to address this problem, the warnings indicate that a discussion is needed around which incentives and regulatory [...]
Posted in FDA, Global, Market Access, R&D, Regulatory, Safety, Strategy, pricing | Also tagged , , , | 1 Comment

Sequestration: How Big a Hit for FDA, Research and Pharma?

By Jill Wechsler | Published: March 12, 2013
The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Posted in FDA, Legal, R&D, healthcare, leadership | Also tagged , , , , , , | Leave a comment